During an NAMCP 2016 Fall Managed Care Forum presentation, Joel W Neal, MD, PhD, discussed how to integrate novel personalized therapies, such as immunotherapy, into non-small cell lung cancer (NSCLC) treatment plans to optimize outcomes.
During an NAMCP 2016 Fall Managed Care Forum presentation, Joel W Neal, MD, PhD, discussed how to integrate novel personalized therapies, such as immunotherapy, into non-small cell lung cancer (NSCLC) treatment plans to optimize outcomes.
During an NAMCP 2016 Fall...